April 27, 2023
National outlets including U.S. News & World Report highlighted research presented by the University of Cincinnati's Alberto Espay on promising new treatments for Parkinson's disease.
September 22, 2023
Drugs.com and HealthDay highlighted University of Cincinnati research recently published in JAMA that found using blood pressure medications to lower the top number of blood pressure readings (systolic blood pressure) may not be safe or effective among people who have an acute ischemic stroke and undergo a successful mechanical clot removal.
September 21, 2023
The University of Cincinnati's Joseph Broderick, MD, recently joined the Know Stroke Podcast to discuss the current state of stroke research, including the FASTEST trial he is leading to test a potential treatment for strokes caused by ruptured blood vessels in the brain.
December 8, 2023
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.
November 9, 2023
The Cincinnati Business Courier highlighted the UC Gardner Neuroscience Institute's recent renewal to continue to serve as the National Coordinating Center for the National Institutes of Health StrokeNet program that conducts clinical trials and research studies to advance stroke treatment, prevention and recovery.
November 15, 2023
Clinical Research News highlighted recommendations to improve recruitment in acute stroke trials, led by UC's Joseph Broderick, following the Stroke Treatment Academic Industry Roundtable XII earlier this year.
March 18, 2024
WCPO highlighted the Steps for Stroke 2024 event, raising money to advance stroke research at the University of Cincinnati.
February 16, 2024
Medscape highlighted Project ECHO, a program piloted at the University of Cincinnati that trains primary care providers to manage epilepsy.
March 19, 2024
MSN and Neurology Live covered the results of a phase 3 trial co-led by a University of Cincinnati researcher that found Parkinson’s disease medication delivered through an infusion pump is safe and effective at reducing symptoms for longer periods of time.
May 22, 2024
TCT MD included comments from the University of Cincinnati's Eva Mistry in a story recapping trial data presented at the European Stroke Organisation Conference that found clot-busting drug tenectaplase is becoming a first-choice treatment in certain situations.